Ropivacaine Hydrochloride Injection, Solution
Product Images NDC 43066-152

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ropivacaine Hydrochloride (NDC 43066-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100ml-bag-label-image-02 (100ml Bag Label Image 02)

FDA Label Image

100ml-carton-label-04 (100ml Carton Label 04)

FDA Label Image

100ml-overwrap-label-03 (100ml Overwrap Label 03)

100ml-overwrap-label-03 (100ml Overwrap Label 03)
Ropivacaine Hydrochloride Injection, USP is a medication used for infiltration, nerve block, and epidural administration. It should not be administered intravenously. Each milliliter contains 2mg of Ropivacaine HCI and 8.6mg of sodium chloride. The pH is adjusted to 4.0 to 6.0 using sodium hydroxide and/or hydrochloric acid. This medication is sterile and should be used immediately after opening. The unused portion should be discarded. The usual dosage information can be found in the package insert. It is recommended to store this medication at a temperature of 20°C to 25°C. The container closure is free from natural rubber latex or Polyvinyl Chloride (PVC), Non-DEHP. This product is manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA and is made in India. The provided code number is DRUGS/AP/01/2008, and the latest revision is in October 2023. The barcode identification is GS1-128: (01)00343066152017.*
FDA Label Image

100ml-sticker-label-05 (100ml Sticker Label 05)

FDA Label Image

200ml-bag-label-image-06 (200ml Bag Label Image 06)

200ml-bag-label-image-06 (200ml Bag Label Image 06)
This text is a description of a medication called Ropivacaine Hydrochloride Injection. It is indicated for use in infiltration, nerve block, and epidural administration. It should not be administered intravenously. Each mL of the injection contains 2 mg of Ropivacaine HCI and 8.6 mg of sodium chloride. The pH of the injection is adjusted to be between 4.0 and 6.0. The injection is sterile and should be used immediately after opening. It is single-use only, and any unused portion should be discarded. The usual dosage instructions can be found in the package insert. The injection should be stored at a controlled room temperature of 20°C to 25°C (68° to 77°F). The container closure does not contain natural rubber latex or Polyvinyl Chloride (PVC), Non-DEHP. The medication is manufactured for Baxter Healthcare Corporation in Deerfield, IL, USA, but it is made in India. The medication contains a unique code number and barcode for tracking purposes. The batch details such as lot number and expiration date should be printed on the packaging.*
FDA Label Image

200ml-carton-label-08 (200ml Carton Label 08)

FDA Label Image

200ml-overwrap-label-07 (200ml Overwrap Label 07)

200ml-overwrap-label-07 (200ml Overwrap Label 07)
This text appears to be the package insert information for a medication. The medication is labeled with the NDC code 43066-154-01 and the brand name has the initials "LG TR T 1] T." The medication is intended for infiltration, nerve block, and epidural administration. It contains 400 mg of a substance called Ropivacaine HCI per 200 mL of solution, which is equivalent to a concentration of 2 mg/mL. It is important to note that this medication is not intended for intravenous administration. Each milliliter of the solution also contains sodium chloride and the pH is adjusted using sodium hydroxide and/or hydrochloric acid. There are no preservatives in the solution. The instructions state that the medication is single-use only, and any unused portion should be discarded. It is also necessary to use the medication immediately after opening, as it is sterile. The usual dosage information is provided in the package insert. Proper storage of the medication is recommended at a temperature between 20°C to 25°C (68°F to 77°F), following the standards of USP Controlled Room Temperature. The container closure of the medication does not contain natural rubber latex or Polyvinyl Chloride (PVC), specifically mentioning that it is Non-DEHP. The medication is manufactured by Baxter Healthcare Corporation located in Deerfield, IL, USA, but it is made in India. The document also includes various additional codes and a barcode (GS1-128) for tracking purposes.*
FDA Label Image

200ml-sticker-label-09 (200ml Sticker Label 09)

FDA Label Image

Structural-formula-ropivacaine-01 (Structural Formula Ropivacaine 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.